Small retail holders can see quite a few outstanding biotechs on the ASX right now with good medium term chances of success and are selling out of IMU to buy them.? On another note, would be interesting to hear the views of Prof Yuman Fong on the extreme negativity of most shareholders about the performance of management. Is he still happy with how the trials and science are going?
IMU Price at posting:
1.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)